Veradigm to acquire ScienceIO for $140M in cash

Veradigm announced that it has signed a definitive agreement to acquire ScienceIO. The transaction has been unanimously approved by the Veradigm board and is expected to close as promptly as practicable following the satisfaction of customary closing conditions. Founded in 2019, ScienceIO is an AI platform and foundation model provider for healthcare. The transaction will be funded through cash on hand and is not subject to a financing condition. The purchase price to be paid for ScienceIO is $140M in cash, an aggregate of approximately $44M of which is deferred and substantially all of which is payable in installments on each of the first three anniversaries of the closing date.